Advances in type I diabetes associated tolerance mechanisms

Scandinavian Journal of Immunology

Volumn 68, Issue 1, 2008, Pages 1-11

  Chentoufi, A A ^a   Binder, N R ^a   Berka, N ^b   Abunadi, T ^c   Polychronakos, C ^d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALGARY   (Canada)

^c BioToxSciences   (United States)

^d RESEARCH INSTITUTE OF THE MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; INTERLEUKIN 2; TRANSCRIPTION FACTOR FOXP3;

AUTOIMMUNE DISEASE; CD4+ CD25+ T LYMPHOCYTE; CELL DIFFERENTIATION; DENDRITIC CELL; HUMAN; IMMUNOLOGICAL TOLERANCE; INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; REVIEW; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; THYMUS;

ANIMALS; DIABETES MELLITUS, TYPE 1; EPITHELIAL CELLS; HUMANS; IMMUNE TOLERANCE; T-LYMPHOCYTES; THYMUS GLAND;

EID: 44849107685     PISSN: 03009475     EISSN: 13653083     Source Type: Journal    
DOI: 10.1111/j.1365-3083.2008.02120.x     Document Type: Review

References (98)

1. Di Lorenzo TP, Peakman M, Roep BO. Translational mini-review series on type 1 diabetes: systematic analysis of T cell epitopes in autoimmune diabetes. Clin Exp Immunol 2007 148 : 1 16.
2. Starr TK, Jameson SC, Hogquist KA. Positive and negative selection of T cells. Annu Rev Immunol 2003 21 : 139 76.
3. Walker LS, Abbas AK. The enemy within: keeping self-reactive T cells at bay in the periphery. Nat Rev Immunol 2002 2 : 11 9.
4. Ohashi PS. Negative selection and autoimmunity. Curr Opin Immunol 2003 15 : 668 76.
5. Chentoufi AA, Palumbo M, Polychronakos C. Proinsulin expression by Hassall's corpuscles in the mouse thymus. Diabetes 2004 53 : 354 9.
6. Chentoufi AA, Polychronakos C. Insulin expression levels in the thymus modulate insulin-specific autoreactive T-cell tolerance: the mechanism by which the IDDM2 locus may predispose to diabetes. Diabetes 2002 51 : 1383 90.
7. Kyewski B, Klein L. A central role for central tolerance. Annu Rev Immunol 2006 24 : 571 606.
8. Pitkanen J, Peterson P. Autoimmune regulator: from loss of function to autoimmunity. Genes Immun 2003 4 : 12 21.
9. Anderson MS, Venanzi ES, Klein L et al. Projection of an immunological self shadow within the thymus by the aire protein. Science 2002 298 : 1395 401.
10. Cabarrocas J, Cassan C, Magnusson F et al. Foxp3+ CD25+ regulatory T cells specific for a neo-self-antigen develop at the double-positive thymic stage. Proc Natl Acad Sci U S A 2006 103 : 8453 8.
11. Aschenbrenner K, D'Cruz LM, Vollmann EH et al. Selection of Foxp3(+) regulatory T cells specific for self antigen expressed and presented by Aire(+) medullary thymic epithelial cells. Nat Immunol 2007 8 : 351 8.
12. Boyd RL, Tucek CL, Godfrey DI et al. The thymic microenvironment. Immunol Today 1993 14 : 445 59.
13. Patel DD, Whichard LP, Radcliff G, Denning SM, Haynes BF. Characterization of human thymic epithelial cell surface antigens: phenotypic similarity of thymic epithelial cells to epidermal keratinocytes. J Clin Immunol 1995 15 : 80 92.
14. Nossal GJ. Negative selection of lymphocytes. Cell 1994 76 : 229 39.
15. Stockinger B. T lymphocyte tolerance: from thymic deletion to peripheral control mechanisms. Adv Immunol 1999 71 : 229 65.
16. Hanahan D. Peripheral-antigen-expressing cells in thymic medulla: factors in self-tolerance and autoimmunity. Curr Opin Immunol 1998 10 : 656 62.
17. Klein L, Klein T, Ruther U, Kyewski B. CD4 T cell tolerance to human C-reactive protein, an inducible serum protein, is mediated by medullary thymic epithelium. J Exp Med 1998 188 : 5 16.
18. Throsby M, Pleau J, Dardenne M, Homo-Delarche F. Thymic expression of the pancreatic endocrine hormones. Neuroimmunomodulation 1999 6 : 108 14.
19. Derbinski J, Schulte A, Kyewski B, Klein L. Promiscuous gene expression in medullary thymic epithelial cells mirrors the peripheral self. Nat Immunol 2001 2 : 1032 9.
20. Cloosen S, Arnold J, Thio M, Bos GM, Kyewski B, Germeraad WT. Expression of tumor-associated differentiation antigens, MUC1 glycoforms and CEA, in human thymic epithelial cells: implications for self-tolerance and tumor therapy. Cancer Res 2007 67 : 3919 26.
21. Liu YJ, Soumelis V, Watanabe N et al. TSLP: an epithelial cell cytokine that regulates T cell differentiation by conditioning dendritic cell maturation. Annu Rev Immunol 2006 25 : 193 219.
22. Watanabe N, Wang YH, Lee HK et al. Hassall's corpuscles instruct dendritic cells to induce CD4+CD25+ regulatory T cells in human thymus. Nature 2005 436 : 1181 5.
23. Eisenbarth GS. Type I diabetes mellitus. A chronic autoimmune disease. N Engl J Med 1986 314 : 1360 8.
24. Ghosh S, Palmer SM, Rodrigues NR et al. Polygenic control of autoimmune diabetes in nonobese diabetic mice. Nat Genet 1993 4 : 404 9.
25. Todd JA, Reed PW, Prins JB et al. Dissection of the pathophysiology of type 1 diabetes by genetic analysis. Autoimmunity 1993 15 (Suppl. 16 7.
26. Wherrett DK, Singer SM, McDevitt HO. Reduction in diabetes incidence in an I-Ag7 transgenic nonobese diabetic mouse line. Diabetes 1997 46 : 1970 4.
27. Pomerleau DP, Bagley RJ, Serreze DV, Mathews CE, Leiter EH. Major histocompatibility complex-linked diabetes susceptibility in NOD/Lt mice: subcongenic analysis localizes a component of Idd16 at the H2-D end of the diabetogenic H2(g7) complex. Diabetes 2005 54 : 1603 6.
28. Deruytter N, Boulard O, Garchon HJ. Mapping non-class II H2-linked loci for type 1 diabetes in nonobese diabetic mice. Diabetes 2004 53 : 3323 7.
29. Wicker LS, Moule CL, Fraser H et al. Natural genetic variants influencing type 1 diabetes in humans and in the NOD mouse. Novartis Found Symp 2005 267 : 57 65 discussion 65-75.
30. Lundholm M, Motta V, Lofgren-Burstrom A et al. Defective induction of CTLA-4 in the NOD mouse is controlled by the NOD allele of Idd3/IL-2 and a novel locus (Ctex) telomeric on chromosome 1. Diabetes 2006 55 : 538 44.
31. Motta V, Lejon K, Holmberg D. The NOD allele of the Idd5 locus on chromosome 1 mediates a non-cell-autonomous defect in negative selection of T cells. J Autoimmun 2007 28 : 216 23.
32. Zucchelli S, Holler P, Yamagata T, Roy M, Benoist C, Mathis D. Defective central tolerance induction in NOD mice: genomics and genetics. Immunity 2005 22 : 385 96.
33. Kishimoto H, Sprent J. A defect in central tolerance in NOD mice. Nat Immunol 2001 2 : 1025 31.
34. Lesage S, Hartley SB, Akkaraju S, Wilson J, Townsend M, Goodnow CC. Failure to censor forbidden clones of CD4 T cells in autoimmune diabetes. J Exp Med 2002 196 : 1175 88.
35. Villunger A, Marsden VS, Strasser A. Efficient T cell receptor-mediated apoptosis in nonobese diabetic mouse thymocytes. Nat Immunol 2003 4 : 717 8.
36. Liston A, Lesage S, Gray DH et al. Generalized resistance to thymic deletion in the NOD mouse; a polygenic trait characterized by defective induction of Bim. Immunity 2004 21 : 817 30.
37. Jahromi MM, Eisenbarth GS. Genetic determinants of type 1 diabetes across populations. Ann N Y Acad Sci 2006 1079 : 289 99.
38. Pugliese A, Zeller M, Fernandez A Jr. et al. The insulin gene is transcribed in the human thymus and transcription levels correlated with allelic variation at the INS VNTR-IDDM2 susceptibility locus for type 1 diabetes. Nat Genet 1997 15 : 293 7.
39. Vafiadis P, Bennett ST, Todd JA et al. Insulin expression in human thymus is modulated by INS VNTR alleles at the IDDM2 locus. Nat Genet 1997 15 : 289 92.
40. Rieck M, Arechiga A, Onengut-Gumuscu S, Greenbaum C, Concannon P, Buckner JH. Genetic variation in PTPN22 corresponds to altered function of T and B lymphocytes. J Immunol 2007 179 : 4704 10.
41. Onengut-Gumuscu S, Concannon P. Recent advances in the immunogenetics of human type 1 diabetes. Curr Opin Immunol 2006 18 : 634 8.
42. Ueda H, Howson JM, Esposito L et al. Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature 2003 423 : 506 11.
43. Smyth DJ, Cooper JD, Bailey R et al. A genome-wide association study of nonsynonymous SNPs identifies a type 1 diabetes locus in the interferon-induced helicase (IFIH1) region. Nat Genet 2006 38 : 617 9.
44. Hakonarson H, Grant SF, Bradfield JP et al. A genome-wide association study identifies KIAA0350 as a type 1 diabetes gene. Nature 2007 448 : 591 4.
45. Todd JA, Walker NM, Cooper JD et al. Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes. Nat Genet 2007 39 : 857 64.
46. Faideau B, Lotton C, Lucas B et al. Tolerance to proinsulin-2 is due to radioresistant thymic cells. J Immunol 2006 177 : 53 60.
47. Brimnes MK, Jensen T, Jorgensen TN, Michelsen BK, Troelsen J, Werdelin O. Low expression of insulin in the thymus of non-obese diabetic mice. J Autoimmun 2002 19 : 203 13.
48. Thebault-Baumont K, Dubois-Laforgue D, Krief P et al. Acceleration of type 1 diabetes mellitus in proinsulin 2-deficient NOD mice. J Clin Invest 2003 111 : 851 7.
49. Nakayama M, Babaya N, Miao D et al. Long-term prevention of diabetes and marked suppression of insulin autoantibodies and insulitis in mice lacking native insulin B9-23 sequence. Ann N Y Acad Sci 2006 1079 : 122 9.
50. Nakayama M, Babaya N, Miao D, Sikora K, Elliott JF, Eisenbarth GS. Thymic expression of mutated B16: a preproinsulin messenger RNA does not reverse acceleration of NOD diabetes associated with insulin 2 (thymic expressed insulin) knockout. J Autoimmun 2005 25 : 193 8.
51. Nakayama M, Abiru N, Moriyama H et al. Prime role for an insulin epitope in the development of type 1 diabetes in NOD mice. Nature 2005 435 : 220 3.
52. Anderson MS, Venanzi ES, Chen Z, Berzins SP, Benoist C, Mathis D. The cellular mechanism of Aire control of T cell tolerance. Immunity 2005 23 : 227 39.
53. Turunen JA, Wessman M, Forsblom C et al. Association analysis of the AIRE and insulin genes in Finnish type 1 diabetic patients. Immunogenetics 2006 58 : 331 8.
54. Jiang W, Anderson MS, Bronson R, Mathis D, Benoist C. Modifier loci condition autoimmunity provoked by Aire deficiency. J Exp Med 2005 202 : 805 15.
55. Niki S, Oshikawa K, Mouri Y et al. Alteration of intra-pancreatic target-organ specificity by abrogation of Aire in NOD mice. J Clin Invest 2006 116 : 1292 301.
56. Chin RK, Lo JC, Kim O et al. Lymphotoxin pathway directs thymic Aire expression. Nat Immunol 2003 4 : 1121 7.
57. Taylor PA, Noelle RJ, Blazar BR. CD4(+)CD25(+) immune regulatory cells are required for induction of tolerance to alloantigen via costimulatory blockade. J Exp Med 2001 193 : 1311 8.
58. Singh B, Read S, Asseman C et al. Control of intestinal inflammation by regulatory T cells. Immunol Rev 2001 182 : 190 200.
59. Belkaid Y, Blank RB, Suffia I. Natural regulatory T cells and parasites: a common quest for host homeostasis. Immunol Rev 2006 212 : 287 300.
60. Lewkowich IP, Herman NS, Schleifer KW et al. CD4+CD25+ T cells protect against experimentally induced asthma and alter pulmonary dendritic cell phenotype and function. J Exp Med 2005 202 : 1549 61.
61. Dittmer U, He H, Messer RJ et al. Functional impairment of CD8(+) T cells by regulatory T cells during persistent retroviral infection. Immunity 2004 20 : 293 303.
62. Iwashiro M, Messer RJ, Peterson KE, Stromnes IM, Sugie T, Hasenkrug KJ. Immunosuppression by CD4+ regulatory T cells induced by chronic retroviral infection. Proc Natl Acad Sci U S A 2001 98 : 9226 30.
63. Cozzo C, Lerman MA, Boesteanu A, Larkin J III., Jordan MS, Caton AJ. Selection of CD4+CD25+ regulatory T cells by self-peptides. Curr Top Microbiol Immunol 2005 293 : 3 23.
64. Jordan MS, Boesteanu A, Reed AJ et al. Thymic selection of CD4+CD25+ regulatory T cells induced by an agonist self-peptide. Nat Immunol 2001 2 : 301 6.
65. Sakaguchi S, Ono M, Setoguchi R et al. Foxp3+ CD25+ CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease. Immunol Rev 2006 212 : 8 27.
66. Shevach EM, DiPaolo RA, Andersson J, Zhao DM, Stephens GL, Thornton AM. The lifestyle of naturally occurring CD4+ CD25+ Foxp3+ regulatory T cells. Immunol Rev 2006 212 : 60 73.
67. Thornton AM, Shevach EM. CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J Exp Med 1998 188 : 287 96.
68. Shimizu J, Yamazaki S, Takahashi T, Ishida Y, Sakaguchi S. Stimulation of CD25(+)CD4(+) regulatory T cells through GITR breaks immunological self-tolerance. Nat Immunol 2002 3 : 135 42.
69. Shevach EM, McHugh RS, Piccirillo CA, Thornton AM. Control of T-cell activation by CD4+ CD25+ suppressor T cells. Immunol Rev 2001 182 : 58 67.
70. Tang Q, Henriksen KJ, Bi M et al. In vitro-expanded antigen-specific regulatory T cells suppress autoimmune diabetes. J Exp Med 2004 199 : 1455 65.
71. Sakaguchi S. Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self. Nat Immunol 2005 6 : 345 52.
72. Salomon B, Lenschow DJ, Rhee L et al. B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes. Immunity 2000 12 : 431 40.
73. Tang Q, Henriksen KJ, Boden EK et al. Cutting edge: CD28 controls peripheral homeostasis of CD4+CD25+ regulatory T cells. J Immunol 2003 171 : 3348 52.
74. Herman AE, Freeman GJ, Mathis D, Benoist C. CD4+CD25+ T regulatory cells dependent on ICOS promote regulation of effector cells in the prediabetic lesion. J Exp Med 2004 199 : 1479 89.
75. Chen Z, Herman AE, Matos M, Mathis D, Benoist C. Where CD4+CD25+ T reg cells impinge on autoimmune diabetes. J Exp Med 2005 202 : 1387 97.
76. Baecher-Allan C, Hafler DA. Human regulatory T cells and their role in autoimmune disease. Immunol Rev 2006 212 : 203 16.
77. Homann D, von Herrath M. Regulatory T cells and type 1 diabetes. Clin Immunol 2004 112 : 202 9.
78. Gregori S, Giarratana N, Smiroldo S, Adorini L. Dynamics of pathogenic and suppressor T cells in autoimmune diabetes development. J Immunol 2003 171 : 4040 7.
79. You S, Belghith M, Cobbold S et al. Autoimmune diabetes onset results from qualitative rather than quantitative age-dependent changes in pathogenic T-cells. Diabetes 2005 54 : 1415 22.
80. Brusko T, Atkinson M. Treg in type 1 diabetes. Cell Biochem Biophys 2007 48 : 165 75.
81. Lindley S, Dayan CM, Bishop A, Roep BO, Peakman M, Tree TI. Defective suppressor function in CD4(+)CD25(+) T-cells from patients with type 1 diabetes. Diabetes 2005 54 : 92 9.
82. Schimpl A, Berberich I, Kneitz B et al. IL-2 and autoimmune disease. Cytokine Growth Factor Rev 2002 13 : 369 78.
83. Klebb G, Autenrieth IB, Haber H et al. Interleukin-2 is indispensable for development of immunological self-tolerance. Clin Immunol Immunopathol 1996 81 : 282 6.
84. Malek TR, Yu A, Vincek V, Scibelli P, Kong L. CD4 regulatory T cells prevent lethal autoimmunity in IL-2Rbeta-deficient mice Implications for the nonredundant function of IL-2. Immunity 2002 17 : 167 78.
85. Antov A, Yang L, Vig M, Baltimore D, Van Parijs L. Essential role for STAT5 signaling in CD25+CD4+ regulatory T cell homeostasis and the maintenance of self-tolerance. J Immunol 2003 171 : 3435 41.
86. Snow JW, Abraham N, Ma MC, Herndier BG, Pastuszak AW, Goldsmith MA. Loss of tolerance and autoimmunity affecting multiple organs in STAT5A/5B-deficient mice. J Immunol 2003 171 : 5042 50.
87. Almeida AR, Legrand N, Papiernik M, Freitas AA. Homeostasis of peripheral CD4+ T cells: IL-2R alpha and IL-2 shape a population of regulatory cells that controls CD4+ T cell numbers. J Immunol 2002 169 : 4850 60.
88. Malek TR, Bayer AL. Tolerance, not immunity, crucially depends on IL-2. Nat Rev Immunol 2004 4 : 665 74.
89. Gavin MA, Clarke SR, Negrou E, Gallegos A, Rudensky A. Homeostasis and anergy of CD4(+)CD25(+) suppressor T cells in vivo. Nat Immunol 2002 3 : 33 41.
90. de la Rosa M, Rutz S, Dorninger H, Scheffold A. Interleukin-2 is essential for CD4+CD25+ regulatory T cell function. Eur J Immunol 2004 34 : 2480 8.
91. Fontenot JD, Rasmussen JP, Gavin MA, Rudensky AY. A function for interleukin 2 in Foxp3-expressing regulatory T cells. Nat Immunol 2005 6 : 1142 51.
92. Denny P, Lord CJ, Hill NJ et al. Mapping of the IDDM locus Idd3 to a 0.35-cM interval containing the interleukin-2 gene. Diabetes 1997 46 : 695 700.
93. Wicker LS, Todd JA, Peterson LB. Genetic control of autoimmune diabetes in the NOD mouse. Annu Rev Immunol 1995 13 : 179 200.
94. Yamanouchi J, Rainbow D, Serra P et al. Interleukin-2 gene variation impairs regulatory T cell function and causes autoimmunity. Nat Genet 2007 39 : 329 37.
95. Brunkow ME, Jeffery EW, Hjerrild KA et al. Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat Genet 2001 27 : 68 73.
96. Fontenot JD, Gavin MA, Rudensky AY. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol 2003 4 : 330 6.
97. Khattri R, Cox T, Yasayko SA, Ramsdell F. An essential role for Scurfin in CD4+CD25+ T regulatory cells. Nat Immunol 2003 4 : 337 42.
98. Jaeckel E, von Boehmer H, Manns MP. Antigen-specific FoxP3-transduced T-cells can control established type 1 diabetes. Diabetes 2005 54 : 306 10.